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Background: Professional networks are used increasingly in health care to bring together members from different
sites and professions to work collaboratively. Key players within these networks are known to affect network
function through their central or brokerage position and are therefore of interest to those who seek to optimise
network efficiency. However, their identity may not be apparent. This study using social network analysis to ask: (1)
Who are the key players of a new translational research network (TRN)? (2) Do they have characteristics in
common? (3) Are they recognisable as powerful, influential or well connected individuals?
Methods: TRN members were asked to complete an on-line, whole network survey which collected demographic
information expected to be associated with key player roles, and social network questions about collaboration in
current TRN projects. Three questions asked who they perceived as powerful, influential and well connected.
Indegree and betweenness centrality values were used to determine key player status in the actual and perceived
networks and tested for association with demographic and descriptive variables using chi square analyses.
Results: Response rate for the online survey was 76.4% (52/68). The TRN director and manager were identified as
key players along with six other members. Only two of nine variables were associated with actual key player status;
none with perceived. The main finding was the mismatch between actual and perceived brokers. Members
correctly identified two of the three central actors (the two mandated key roles director and manager) but there
were only three correctly identified actual brokers among the 19 perceived brokers. Possible reasons for the
mismatch include overlapping structures and weak knowledge of members.
Conclusions: The importance of correctly identifying these key players is discussed in terms of network
interventions to improve efficiency.Background
Key players can be crucial to the effective functioning of
any network [1] and there is interest in looking at how
we can support their role in improving network out-
comes [2,3]. Key players are those people that are seen
as well connected and well informed. They are opinion
leaders or have power and influence. They have roles in
coordinating effort and bridging gaps.
Professional networks are used increasingly in health
care to organize groups of people across organisational
and disciplinary boundaries, for example clinical net-
works that seek to develop new treatment and care path-
ways [4,5], chronic disease networks that bridge the gaps* Correspondence: janet.long@unsw.edu.au
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reproduction in any medium, provided the orbetween hospital and community services and seek to
integrate care [6,7], and translational research networks
that drive collaborative interdisciplinary endeavours be-
tween universities and health care settings [8]. Despite
their rise in use throughout health care, our understand-
ing of the processes and structural features of such net-
works, and how they contribute to network outcomes is
limited [4,9]. Our understanding of the role of key
players in this is also limited especially in the health care
setting as research has been largely undertaken in com-
mercial and competitive settings [10,11]. A deeper un-
derstanding of the role of key players in collaborative
health care settings is therefore essential. Evidence from
such research can then be used to develop interventions
to support beneficial key player functions and mitigate
any costs of the role.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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care structures such as hospitals, and negotiations be-
tween members are social interactions, built on trust.
While we may intuitively understand key players and net-
works in general, social network analysis allows us to
examine these social interactions empirically. Network
analysis measures the relationships and interactions be-
tween members (actors) rather than their individual attri-
butes. Networks are made up of nodes (the actors) and
ties (the relationship links) between them and whole net-
work and individual actor parameters can be calculated.
The ties form the structure of the network and actors are
said to hold positions within that structure [12]. Table 1
summarises social network terms used in this paper.
Two network positions, the central actor and the bro-
ker, are considered key to network function and out-
come [1,2]. The actor who is most central, with ties to
the most other actors, has been shown to co-ordinate
communication and effort across the network [13]. Cen-
tral actors (or more correctly here, prestigious actors
[18]) are often seen as experts or opinion leaders [19]
and are the most sought after for advice within the net-
work. These centrality characteristics make networks
vulnerable to the loss of key players [1].
Brokers lie between actors who would not otherwise be
linked, and facilitate transactions and the flow of informa-
tion between them [10]. Within health care the presence
of organisational silos and professional “tribes” mean that
there are many such gaps between members [20-22]. Gaps
between these unlinked agents may also be due to geo-
graphic position (for example members from different
wards, hospitals or health regions), cultural or discipline
specific differences (including seniority or status) orTable 1 Social network terms [13-17]
Term Definition
Actor Member of a network.
Broker A go-between or bridge, linking two other actors that are
not themselves linked.
Central
actor
The actor who is nominated most often or who interacts
with the most others in their network.
Indegree The number of ties directed to a focal actor. E.g. if 5 people
nominate Mary as a collaborative partner, Mary’s indegree is 5.
Network A group of people having some form of interaction
between them.
Node Actors in a sociogram are depicted as nodes connected by ties.
Outdegree The number of ties that an individual actor directs to other
actors. E.g. if Mary nominates 3 people as her collaborative
partners, Mary’s out degree is 3.
Sociogram Graphical representation of the relationships between
actors in a network.
Tie Relationship between two actors depicted as a line in a
sociogram. Ties must be clearly defined, as different
relationships will give different patterns of ties (e.g. “who
are your friends?” and “who do you report to?”).alternatively, reflect the fact that parties have little basis on
which to trust others [10,23]. Brokers seem to be crucial
to connecting marginalised or isolated members and for
bridging boundaries imposed by hierarchy or perceived
power [2]. Loss of a broker may result in the network frag-
menting or compromising communication pathways [24].
Both central and brokerage roles have the potential to
become onerous to the individual and may introduce
workflow or communication bottlenecks which decrease
network efficiency [25,26].
Formal network reporting and communication struc-
tures do not always match the informal or social struc-
tures that “actually get the work done” [27,28]. This has
given rise to the concept of the “invisible network”
[29,30]. Formal mandated roles and key player roles
often overlap; the appointed network leader for example,
is often the central actor. However, the role of other ac-
tors may be less visible. One may know exactly what is
happening among one’s close and regular contacts (or
strong ties) but it is more difficult to be aware of the ties
among one’s less frequent contacts (or weaker ties)
[28,31]. Therefore interventions that seek to support key
players must first start by accurately identifying them
and the network functions they influence [32].
We chose a translational research network (TRN) as a
case study to explore the key player role in a health care
setting. TRNs are designed to increase the focus of
knowledge translation in health care [33,34], bringing to-
gether university-based researchers and hospital-based
clinicians to develop new clinical practices and introduce
them into routine patient care. Translational research is
considered a priority in the research agenda of many
countries for example the nine Collaboratives for Lead-
ership in Applied Health Research & Care (CLAHRCs)
in England and the large number of interorganisational
alliances funded by the Clinical and Translation Science
Awards in the US. Collaboration [35-38], innovation
[39-41], knowledge exchange [36,42] and diffusion of
findings [43-45] are all intended outcomes of TRNs. Key
players have been associated with all these functions in a
range of network settings [11,19,26,46-48]. It is these in-
formal positions in a network that have been linked to
increased idea generation and knowledge translation
[49]. Gray [2] writing more generally about transdisci-
plinary networks hypothesized that brokers would be
critical to bridge the gaps between the disciplines, while
Haines and colleagues [50] see central actors as neces-
sary for co-ordinating effort and disseminating findings
in an academic transdisciplinary collaboration. So while
these roles have been explored in other network settings
they have yet to be examined within TRNs.
The importance for research to examine key players in
TRNs was highlighted in a major international review of
funding mechanisms designed to support the translation
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gles to get linkages between agencies, researchers, and
decision makers [51]. It implied that further research
examining the network dynamics of these TRNs would
help lead to better strategies to support the translation
of evidence into practice. Another study looking at
knowledge translation networks in the clinical domain
reiterated this point, and highlighted the need for further
research to focus on understanding the role knowledge
brokers play in such networks [33].
In response to the need for advancing this area, this
paper explores the important area of the informal posi-
tions in a network; [49] an area which can readily be
addressed by social network analysis [52]. It highlights
where the informal positions of influence and brokering
are, if they are linked to any traditional characteristics of
power (i.e. expert power), and if others recognise the in-
formal network positions as having influence. Specific-
ally, the paper asks three questions:
1. Who are the brokers and central actors in a network
of current collaborators in a new TRN?
2. Do the key players have demographic and
descriptive characteristics in common? For example,
are the identified key players all clinicians, or senior
academics, or have similar opinions about network
barriers and their own role within the network?
3. Are the key players recognisable as powerful,
influential or well connected individuals by other
members of the TRN?
Addressing these questions will help provide guidance
to funders of health based TRNs on how to structure
and manage the networks, the sort of individuals that
should be a part of the network, and the informal net-
work positions that need to be identified and nurtured.
This will go some way to fill the gaps in the knowledge
base identified by international health services research
examining TRNs [33,51].
Methods
Setting
The target TRN was initiated in late 2011 with a member-
ship of 68 clinicians and researchers from 12 hospital and
university campuses in New South Wales, Australia.
The overarching goal of the network is “taking science
to practice,” and is focused on putting clinically proven
knowledge of disease processes, diagnostic or treatment
techniques into routine clinical practice and health
decision-making [53]. The network provides access to
funding for short-term projects, shared databases and fa-
cilities, and support from project officers and translational
research (TR) fellows. This study forms part of a larger
project looking at network structure and key players [54].The TRN is embedded in a pre-existing and complex
inter-organisational network of long-standing research and
teaching arrangements as well as self-initiated collabora-
tive research. TRN activities and funded projects do not
displace existing and ongoing research such as National
Health and Medical Research Council (NH&MRC) funded
projects. At its inception, the TRN was already a collabora-
tive effort as core group members prepared and submitted
the proposal to the funding body. Past collaborative ties
and knowledge of a broad range of clinicians and re-
searchers in the field therefore define the starting point of
the network and give a base line for growth in linkages of
members and new collaborations over time.
Procedures
People listed as full members of the TRN as of January
2012 were asked to complete an on-line, whole network
survey in March 2012, each member receiving a link to
the secure survey site via personal email. Ethics ap-
provals were obtained from the University of New South
Wales and appropriate local health network and site-
specific committees (Additional file 1). Respondents
were assured of anonymity in the reporting of results
(names being replaced by anonymous codes) and were
required to give formal consent. We sought answers
from all members to reflect the whole network, rather
than a sample of members [14,55]. To maximise the re-
sponse rate, three follow-up reminders were emailed to
non-respondents over the succeeding two months.
The survey was divided into two sections (see Additional
file 2). The first section collected demographic and de-
scriptive information (not able to be sourced from
TRN documents), which was expected to be associated
with key player roles: main tasks, seniority, past and
present places of work, previous involvement in trans-
lational research and membership in other relevant
networks or communities of practice. As some mem-
bers have a clinical role as well as a research role, it was
anticipated that the concept of the “two cultures” of
clinician or researcher [56] might not be clear-cut.
Members were therefore asked to choose one title for
themselves from clinician, manager, academic, re-
searcher, clinical-researcher or “other.” We named this
variable “Self Title.” Two survey questions asked about
the importance to respondents of various network bar-
riers and enablers identified in previous interviews as
significant (5 item Likert scale). Other questions asked
about reasons for joining the TRN and specific activities
undertaken so far within the TRN. These questions
were designed so we could categorise members as hav-
ing either an altruistic or opportunistic approach to
joining the network, and an active or passive attitude to
their role in network activities. An altruistic approach
where the actor is committed to the TRN and an active
Table 2 Survey variables used to test for association with
key player status
Variable Survey items
Altruistic approach Deeply committed to the TRN’s objectives,
offering expertise, representing other
workgroups, disseminating findings
Active role Attended formal meetings of the TRN,
initiated meetings, involved in a TRN project,
provided advice for TRN projects
Resources (Cronbach’s
alpha: 0.76)
Enabler: Adequate funding, access to shared
resources and expertise, support of Project
Officers and Fellows Barriers: Lack of
adequate funding
No Incentives
(Cronbach’s alpha: 0.78)
Barriers: Lack of incentives, lack of time, lack of
interest from colleagues, difficulties of
collaborations
Focus (Cronbach’s
alpha: 0.73)
Enablers: Projects focused on patient
outcomes, strong leadership, good
communication, social capital of members
Barriers: Poor or absent links between
researchers and clinicians
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ciated with central actor status particularly.
The second part of the survey asked social network rela-
tionship questions: the participant’s current links to each
other member, as well as perceptions of who were key
players. Each question asked about a different relationship
or interaction and so produced four unique sociograms or
network graphs: Current collaboration, Powerful, Influen-
tial and Well connected.
The Current Collaboration network graph was cons-
tructed from respondents’ answers to two specific ques-
tions: “Who are the people with whom you have consulted
or collaborated regarding any TRN research project” and
“Who are the people with whom you have collaborated re-
garding dissemination of TRN objectives or findings”.
Since centrality is often associated with network power
and influence [10,57] and brokers are often thought of as
well connected, go-betweens or bridges to other groups
[24,29] we asked “who are the most powerful members (in
terms of setting the agenda),” “who are the most influen-
tial members (in terms of achieving TRN outcomes), and
“who are the most highly connected members?” Since the
exact membership of the TRN was known, each question
provided a roster of TRN members’ names, job titles and
primary place of work as an aid to memory.
Key player parameters were calculated for each respond-
ent in each of the four networks using UCInet v6 [58], a
software tool for social network analysis. The parameters
indegree and betweenness centrality were chosen to iden-
tify key players [13-15]. Indegree is a measure of how
many other actors in the network nominated the actor of
interest as a collaborator and is used here to determine
the most central actor. Betweenness centrality measures
the extent to which the actor of interest lies between other
actors that are not themselves linked. It is an indication of
brokerage potential.
Each member was categorised as being an identified
key player in the actual (Current Collaboration) or per-
ceived (Powerful, Influential or Well-connected) net-
works, or not a key player. Chi square analyses were
used to test for any association with demographic varia-
bles of current workplace, gender, membership of other
networks, more than one relevant qualification and sur-
vey answer patterns: altruistic approach, active role and
barriers and enablers.
Results
General
The response rate for the online survey was 76.4% (52/
68). Of these, three responses were incomplete while a
further three members provided answers to the social
network questions separately. Members named 16 differ-
ent current workplaces. Since many workplaces had only
one respondent, workplaces were aggregated into threebroad sites for analysis (Central, Satellite and Peripheral
sites), based partly on geographic proximity and partly
on administrative proximity (largely NSW Local Health
Districts). Sixty three per cent of respondents worked at
a Central Site, 27.8% at a Satellite Site and 9.2% at a
Peripheral Site. A comparison of respondents and non-
respondents showed that they were similar in gender
distribution (χ2 (1, n = 68) 1.85, p = 0.17) and representa-
tion from Central, Satellite and Peripheral Sites (χ2 (2, n =
68) 5.27, p = 0.072). Lowest response rates came from the
Peripheral sites.
Most respondents (87.8%) chose a Self Title of “re-
searcher”, “academic”, “clinician” or “clinician-researcher.”
These categories were aggregated for analysis after consid-
eration of respondent’s stated key tasks, workplace and
qualifications. All who chose “academic” for example,
had stated that research was their key role and were
university-based so were classified “researchers.” This
resulted in 38.8% with a Self Title of “clinician”, 53.7%
“researcher” and 7.4% “clinician-researcher.” Members
overwhelmingly considered themselves experts in their
field (96.3%); 79.6% had over ten years experience in
their field with 33.3% over 20 years.
Survey questions asking how important different fac-
tors were as barriers or facilitators of the network were
explored using factor analysis (principal axis factoring
with Varimax rotation). Three factors (with Eigenvalues
exceeding 1.5) were identified as underlying the 19 sur-
vey items. In total, these factors accounted for around
49% of the variance in the data. Altruistic approach and
Active role variables were generated from respondents’
answers. Table 2 contains a summary of variables tested
for their relationship with key player status.
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gram. The 52 respondents (49 for the Well-Connected
question) gave answers for all 68 TRN members; i.e. we
had outgoing ties for 52 and incoming ties for 68 mem-
bers. We chose to use the matrix of ties just to and from
the respondents after determining that the results were
similar to those where we included and symmetrised in-
coming ties for all 68 members of the TRN (i.e. manu-
ally added an outgoing tie to every incoming tie to a
non-respondent).
Indegree and betweenness centrality values were
computed for each actor in each network using UCInet
[58] and as network size (N) varied between 49 and 52,
normalised in regards to the network size (divided by
1/N and multiplied by 100). The range of values how-
ever were not normally distributed in any of the net-
works examined, each having a marked positive skew
and between one and ten outliers. Since the distribu-
tions defied further standard methods of normalisation
to allow comparisons (square root, natural log and re-
ciprocal), regressions, ANOVAs and t-tests were ruled
out. Instead, outlying actors with scores significantly
above the mean were considered the top ranking key
players in each network and key player status was used
as a categorical variable with chi-square analyses to test
for association with the various demographic and sur-
vey variables. Figure 2 shows boxplots of all four net-
works examined.Figure 1 Current Collaboration network. Central actor LC64 shown in b
JA10 who is both a central actor and a broker is shown in red.1. Who are identified as the key players in the Current
Collaboration network?
Identified central actors (normalised indegree outliers)
in the Current Collaboration network were LC64 (the
TRN director), JA10 (the TRN manager) and EB31 with
normalised indegree scores 25.5, 15.7 and 9.8 respec-
tively. Mean indegree across all members of the network
was 4.0. Identified brokers (betweenness centrality out-
liers) in the Current Collaboration network were: JA10,
the TRN manager with a normalised betweenness cen-
trality of 18.8, followed by Central Site researchers BB28,
EB31, DB30 and KA11, then CC55, a clinician from a
Satellite Site and MA13 a clinician from the Central Site.
Mean betweenness centrality across all members of the
network was 0.9.
2. Do key players have demographic variables or
survey opinions in common?
Holding another relevant qualification and strongly
agreeing with the importance of adequate resources for
the TRN (Resources variable) were the only two vari-
ables to be significantly associated with key player status
in the Current Collaboration network. Workplace and
Self Title were not significantly associated with key
player status. Table 3 summarises the full results of chi-
square analyses.lue, brokers BB28, EB31, DB30, CC55, MA13 and KA11 in yellow and
ab
Figure 2 Boxplots1 of key player values in each of the four networks: Current Collaboration, Powerful, Influential and Well Connected.
(a) Normalised indegree (outliers are top ranking central actors); (b) normalized betweenness centrality (outliers are considered the top ranking
brokers). Actors marked with ** indicate they are both actual and perceived key players.1Boxplots show minimum, first quartile, median, third
quartile, maximum and outliers shown with star or circle. The stars represent values greater than the third quartile plus three times the
interquartile range while circles represent values greater than or equal to the third quartile plus 1.5 times the interquartile range.
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powerful, influential or well connected individuals by
the other members of the TRN?
Members accurately identified two of the three cen-
tral actors in the Current Collaboration network but
only three of the six brokers. Moreover, TRN members
perceived two actors as central actors who were notand 16 actors as brokers who were not. There were
far fewer actors perceived as central actors across the
Powerful, Influential and Well-connected networks
compared to those perceived as brokers (four com-
pared to nineteen).
Respondents saw a difference between being powerful in
terms of setting the agenda, and being influential in terms
of achieving objectives. There are 16 perceived brokers
Table 3 Chi square statistics for identified key players compared to the other TRN members by demographic and
survey variables
Identified key players Variables Chi square value Degrees of freedom Significance
Actual (Current collaboration network)
Gender 0.42 1 0.517
Workplace 2.06 2 0.358
Member of another network <0.01 1 0.971
Other qualifications 6.02 1 0.014*
Resources 5.37 1 0.020*
No incentives 1.64 1 0.200
Focus 1.40 1 0.238
Altruistic approach 0.32 1 0.574
Active role 0.66 1 0.418
Perceived (powerful, influential or well connected networks)
Gender 0.10 1 0.749
Workplace 2.63 2 0.268
Member of another network 0.86 1 0.354
Other qualifications <0.01 1 0.961
Resources 3.00 1 0.083
No incentives 2.54 1 0.096
Focus 0.15 1 0.696
Altruistic approach <0.01 1 0.976
Active role 2.19 1 0.139
*Indicates significance at α = 0.05.
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were identified in both networks. A further five actors
were perceived as brokers in the Well connected network
who were not identified as a broker or central actor else-
where. Table 4 summarises the actual and perceived key
players.
Discussion
This study found that the TRN director was by far the
most central actor in the Current Collaboration network.
This was not surprising as the director had positions
across several sites and had been instrumental in inviting
a large number of members to join the TRN. The TRN
manager’s status as both a central actor and a broker
was consistent with the mandated role as a facilitator
and co-ordinator. The manager had not worked with
any TRN members before joining the staff but had since
worked assiduously to contact and facilitate connections
between members. Factors associated with successful
transdisciplinary teams include leadership that encour-
ages collaboration, manages conflict between groups and
clearly communicates team goals [59]. The director and
manager’s centrality in the TRN places them in the best
position to achieve this. There were six other members
identified as key players, one central actor and fivebrokers. One of the brokers was also on the governing
body, another mandated leadership position.
However, there was a lack of an association between
key player status and most demographic and survey vari-
ables. For example, contrary to expectations, it was
found that an active role in TRN activities (e.g. initiating
a meeting to discuss a TRN project) was not associated
with central actor status. The only significant association
between key player status and the variables examined
was for the survey item Resources and having another
qualification relevant to the TRN. Central actor roles are
often associated with expert status and so an extra quali-
fication that implies a wider knowledge base and en-
hancement of expertise is consistent with this finding.
The Resources survey item reflects the respondents’
strong agreement with the statement that access to the
network’s resources such as shared databases, funding
and Project Officer support are significant enablers of
the network. All the identified key players in the Current
Collaboration network strongly agreed whereas across
the other respondents 24 strongly agreed and 18 agreed
or were neutral. One of the stated roles of the TRN is to
develop these resources and make them accessible to the
members. The four key players in mandated positions
would be especially aware of this and its importance.
Table 4 Identified key players from the actual (Current Collaboration network) and perceived (“Who do you think are
the most powerful or most influential or well-connected members of the TRN?”)
ID Gender Self title Work place Role Central actor Perceived central actor Broker Perceived broker
LC64 F CR Central Director CC P, I, W P, I
JA10 F R Periph Manager CC P, W CC P, I, W
AB27 M R Satellite Gov Body P I
BB28 M R Central Gov Body W CC
EB31 F R Central Member CC I
DB30 M R Central Member CC P, I
KA11 F R Central Member CC
CC55 F C Satellite Member CC
MA13 M C Central Member CC P, W
UA21 M CR Central Gov Body P, I, W
WA23 M R Central Gov Body P
EA5 M R Central Gov Body P
IC61 F R Central Member P,I
SB45 F R Central Member P
NA14 F C Satellite Member P, I
IA9 M C Satellite Member P
PB42 F C Central Member I, W
UB47 F C Central Member I
GC59 F C Central Member W
EC57 F C Central Member W
JB36 M R Satellite Member W
LB38 M C Central Gov Body W
Key: P Powerful, I Influential and W Well-connected, C Clinician, R Researcher, CR Clinician-researcher.
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described by collaboration, it might be assumed that col-
laborators are using these new TRN resources and so
may be especially appreciative of their importance.
The identified key players seem to have little else in
common and this could be due to the historical context
of the TRN. The pre-existing research and teaching rela-
tionships established before the TRN was formed (such
as research grant collaborations or training arrangements
through Clinical Schools) may have a greater influence on
who is in a key player role than current involvement in
TRN activities. Rather than considering the TRN to be a
new network, for some members it may perhaps be per-
ceived as just a reconfiguration of existing contacts.
The third aim of the study was to test whether members
had accurate perceptions of who held key player positions
in the network. This was the most significant finding of the
study: the marked mismatch between actual and perceived
brokers. For example, actor UA21, a clinician-researcher
from the Central Site, is the top ranked broker in the Power-
ful and Well connected networks and ranks second in the
Influential network but is not identified as an actual broker
(or central actor) in the Current Collaboration network. Allthree perceived networks feature brokers that are not identi-
fied as key players in the Current Collaboration network.
This implies that these members have a reputation of an
active role and are well known in the pre-existing research
or formal hospital networks but are not currently involved
in TRN projects. In other words, key player activity in one
setting may not necessarily carry across to another. While
other explanations may be possible for this (e.g. UA21 may
have been on leave during the first funding round) this
does raise the issue of how the picture of who is “getting
things done” [29] is further blurred when multiple net-
works having different member sets and purposes are over-
laid as here: the formal university or hospital organisational
structure, the network of past collaborative ties and now
the TRN. Being aware of people’s roles in each of these
separate network contexts may be difficult to tease out.
The rather simplistic popular conception of the broker-
age role as a well connected individual is another factor
which makes accurate identification of brokers difficult.
While central actors are often fairly obvious as the person
to whom most other members are in contact, the social
network algorithm that computes brokerage potential
measures the extent to which the member lies on the
Long et al. BMC Health Services Research 2013, 13:338 Page 9 of 11
http://www.biomedcentral.com/1472-6963/13/338shortest path between unconnected members which is far
more difficult to see, especially across a whole network.
Brokers have an important role to play in TRNs such as
the network here [2]. The structure of this and many other
TRNs is a hybrid of hierarchical and enclave structures
[60]: hierarchical insofar as it has a central authority in the
director and governing body. However, the general
membership is intended to have a flat structure and
egalitarian access to TRN resources. Brokers can be es-
pecially useful here by bridging and brokering power
gaps that may persist from the more hierarchically
structured hospital and university arenas [2]: bridging
the gap between nurses and doctors or post graduate
students and professors, linking more peripheral mem-
bers (such as allied health clinicians or researchers
based in rural sites) to the centrally located members.
If perceived key players are not necessarily the actual
key players, there are implications for network manage-
ment to consider. Planned interventions or role support
may be targeted at the wrong people: an intervention
aimed at supporting the brokerage role of UA21 in the
Current Collaboration network would clearly be unsuc-
cessful as UA21 is not in the correct position in this net-
work to carry out the brokerage role. It may even
compromise network resilience; since networks are par-
ticularly vulnerable to the loss of central actors and bro-
kers, this risk can only be managed if the actual key
players are identified.
How participants decided that other members were
well connected is not apparent. Only three of the ten
actors identified as key players in the Well connected
network reported being a member of another relevant
network or community of practice which was hypo-
thesised to increase the perception that they are well
connected.
It was expected that central actors would be consid-
ered experts in their field and hence sought out by
others for collaborative engagement. However, the high
number of experts and senior practitioners meant that
this was not apparent. As the membership of the TRN
grows and attracts more members that are less experi-
enced, more junior and not currently engaged in transla-
tional research, expert status may become more closely
linked with key player status.
Strengths and limitations
Survey data collected for social network analyses rely
on accurate self report. Every effort was made to ensure
the accuracy of this data. Care was taken to make the
relationship questions as unambiguous as possible
(through incorporating feedback from earlier inter-
views and a pilot survey). This minimises the risk that
reported ties are understood differently by respondents.
Also a roster of members’ names and positions wasused to provide every opportunity for a full list of col-
laborators to be reported.
There were, as reported earlier, a number of difficul-
ties in analysing the relatively small data set, however
the 76.4% response rate for the whole network was the
best that a concerted follow-up effort directed at non-
respondents could achieve. Aggregating categories de-
creased the power of analyses to show up patterns yet
small frequencies necessitated this approach.
The survey was a snapshot and as such gives no infor-
mation about the growth or efficiency of the network
over time. Follow-up studies planned for a later date
[54] will provide further data to examine changes over
time and to link network structure and key player roles
with network outcomes.
Conclusion
Key players have positions of power and influence in
networks and as such are of interest to people seeking to
understand and optimize network function. Central ac-
tors are often seen as experts and most sought after for
advice within the network while brokers can bridge or
mediate connections between unlinked members. Any
interventions to support key players must begin by cor-
rectly identifying them. This study has empirically iden-
tified these players. Most significantly, the perceptions
about who is holding these influential positions are not
always correct. We found that the TRN director was a
central actor while the TRN manager was both a central
actor and a broker. Both were correctly identified as
such. However, identification of members in brokerage
positions was far less accurate. Suggested reasons for
this include: multiple overlying organizational structures
that may blur what roles are done in what context, over-
simplified ideas about what brokers do and the difficulty
of knowing what happens among network members who
lie outside one’s strong, close ties.
Additional files
Additional file 1: Ethics Approvals.
Additional file 2: TRN Collaboration Survey 1 for BMC HSR.
Competing interests
JL is supported by a PhD Scholarship Top-up Award funded by the Cancer
Institute NSW. No funding partners had a role in this research or papers
published from it.
Authors’ contributions
Study design and analysis was developed by all four authors. JL collected
data, and wrote the paper, PC assisted with analysis, and FC, PC and JB
critically reviewed drafts and the final copy. All authors read and approve the
final manuscript.
Acknowledgements
This work is supported by an ARC Discovery Grant DP 0986493 and NH&MRC
Program Grant 568612.
Long et al. BMC Health Services Research 2013, 13:338 Page 10 of 11
http://www.biomedcentral.com/1472-6963/13/338Author details
1Centre for Clinical Governance Research, Australian Institute of Health
Innovation, University of New South Wales, Kensington 2052, Australia.
2Centre for Primary Health Care Systems Research, Menzies School of Health
Research, Charles Darwin University, Darwin 0815, Australia. 3School of
Population Health, University of Auckland, Auckland 1142, New Zealand.
Received: 4 February 2013 Accepted: 27 August 2013
Published: 30 August 2013
References
1. Borgatti SP: Identifying sets of key players in a social network. Comput
Math Organiz Theor 2006, 12:21.
2. Gray B: Enhancing transdisciplinary research through collaborative
leadership. Am J Prev Med 2008, 35:S124–S132.
3. Valente TW: Network interventions. Science 2012, 337:49–53.
4. Cunningham F, Ranmuthugala G, Westbrook J, Braithwaite J: Net benefits:
assessing the effectiveness of clinical networks in Australia through
qualitative methods. Implement Sci 2012, 7:108.
5. McInnes E, Middleton S, Gardner G, Haines M, Haertsch M, Paul CL, Castaldi
P: A qualitative study of stakeholder views of the conditions for and
outcomes of successful clinical networks. BMC Health Serv Res 2012, 12:49.
doi:10.1186/1472-6963-12-49.
6. Greene A, Pagliari C, Cunningham S, Donnan P, Evans J, Emslie-Smith A,
Morris A, Guthrie B: Do managed clinical networks improve quality of
diabetes care? Evidence from a retrospective mixed methods evaluation.
Qual Saf Health Care 2009, 18:456–461.
7. Fuller J, Perkins D, Parker S, Holdsworth L, Kelly B, Roberts R, Martinez L,
Fragar L: Building effective service linkages in primary mental health
care: a narrative review part 2. BMC Health Serv Res 2011, 11:66.
doi:10.1186/1472-6963-11-66.
8. Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson
SB, Catanese V, Tilson H, Getz K, et al: Central challenges facing the
national clinical research enterprise. JAMA 2003, 289:1278–1287.
9. Braithwaite J, Westbrook JI, Ranmuthugala G, Cunningham F, Plumb J, Wiley
J, Ball D, Huckson S, Hughes C, Johnston B, et al: The development, design,
testing, refinement, simulation and application of an evaluation
framework for communities of practice and social-professional networks.
BMC Health Serv Res 2009, 9:162.
10. Burt RS: Structural holes: the social structure of competition. Cambridge,
Massachusetts: Harvard University Press; 1992.
11. Long J, Cunningham FC, Braithwaite J: Bridges, brokers and boundary
spanners in social professional networks: a systematic review. BMC
Health Serv Res 2013, 13:158.
12. Borgatti SP, Halgin D: On network theory. Organization Science 2011,
22:1168–1181.
13. Freeman LC: Centrality in social networks: conceptual clarification. Social
Networks 1979, 1:215–239.
14. Wasserman S, Faust K: Social network analysis. Cambridge: Cambridge
University Press; 1994.
15. Scott J: Social network analysis: a handbook. 2nd edition. London:
Sage; 2000.
16. Borgatti SP, Mehra A, Brass DJ, Labianca G: Network analysis in the social
sciences. Science 2009, 323:892–895.
17. Newman MEJ, Watts DJ, Strogatz SH: Random graph models of social
networks. Proc Natl Acad Sci U S A 2002, 19:2566–2572.
18. Knoke D, Burt R: Prominence. In Applied Network Analysis. Edited by Burt R,
Minor M. Newbury Park, CA: Sage; 1983:195–222.
19. Valente TW, Pumpuang P: Identifying opinion leaders to promote
behavior change. Health Educ Behav 2007, 34:881–896.
20. Braithwaite J: An empirical assessment of social structural and cultural
change in clinical directorates. Health Care Analysis 2006, 14:185–193.
21. Braithwaite J, Westbrook M: Rethinking clinical organisational structures:
an attitude survey of doctors, nurses and allied health staff in clinical
directorates. J Health Serv Res Policy 2005, 10:10–17.
22. Braithwaite J: Between group behaviour in health care: gaps, edges,
boundaries, disconnections, weak ties, spaces and holes. A systematic
review. BMC Health Serv Res 2010, 10:330.
23. Marsden P: Brokerage behaviour in restricted exchange networks. In
Social structure and network analysis. Edited by Marsden P, Lin N. Beverley
Hills: Sage; 1982:201–218.24. Burt RS: Brokerage and closure: an introduction to social capital. New York:
Oxford University Press; 2005.
25. Marrone JA, Tesluk PE, Carson JB: A multilevel investigation of
antecedents and consequences of team member boundary-spanning
behavior. Acad Manag Ann 2007, 50:1423–1439.
26. Cummings J, Cross R: Structural properties of work groups and their
consequences for performance. Social Networks 2003, 25:197–210.
27. Cross R, Parker A: The hidden power of social networks: understanding how
work really gets done in organizations. Boston, Massachusetts: Harvard
Business School Press; 2004.
28. Krackhardt D, Hanson JR: Informal networks: the company behind the
charts. 1993, 71:104–111.
29. Cross R, Borgatti S, Parker A: Making invisible work visible: using social
network analysis to support strategic collaboration. Calif Manage Rev
2002, 44:25–46.
30. Tsai W, Ghoshal S: Social capital and value creation: the role of intrafirm
networks. Acad Manage J 1998, 41:464–476.
31. Granovetter M: The strength of weak ties: a network theory revisited. Beverly
Hills, CA: Sage; 1982.
32. Chambers D, Wilson P, Thompson C, Harden M: Social network analysis in
healthcare settings: a systematic scoping review. PLoS ONE 2012, 7:e41911.
33. Jansson SM, Benoit C, Casey L, Phillips R, Burns D: In for the long haul:
knowledge translation between academic and nonprofit organizations.
2010, 20:131–143.
34. Tetroe JM, Graham ID, Foy R, Robinson N, Eccles MP, Wensing M: Health
research funding agencies’ support and promotion of knowledge
translation: an international study. Milbank Q 2008, 86:125–155.
35. Field A, Baxter K, Terry SF: From bench to practice to population health
impact: barriers to realizing the public health and clinical promise of
basic scientific discovery. Genet Test Mol Biomarkers 2011, 15:191–192.
36. Tageja N: Bridging the translation gap - new hopes, new challenges.
Fundam Clin Pharmacol 2011, 25:163–171.
37. Tenenbaum JD, Whetzel PL, Anderson K, Borromeo CD, Dinov ID, Gabriel D,
Kirschner B, Mirel B, Morris T, Noy N, et al: The Biomedical Resource
Ontology (BRO) to enable resource discovery in clinical and translational
research. J Biomed Inf 2011, 44:137–145.
38. Zierhut H, Austin J: How inclusion of genetic counselors on the research
team can benefit translational science. Sci Transl Med 2011, 3:74cm77.
doi:10.1126/scitranslmed.3001898.
39. Woolf SH: The meaning of translational research and why it matters.
JAMA 2008, 299:211–213.
40. Zerhouni EA: Translational and clinical science: time for a new vision.
N Engl J Med 2005, 353:1621–1623.
41. National Institutes of Health: Clinical and Translational Science Awards;
2013. http://www.ncats.nih.gov/research/cts/ctsa/ctsa.html, accessed 2
Sept 2013.
42. Goldblatt EM, Lee W-H: From bench to bedside: the growing use of
translational research in cancer medicine. Am J Transl Res 2010, 2:1–18.
43. Rowley E, Morriss R, Currie G, Schneider J: Research into practice: collaboration
for leadership in applied health research and care (CLAHRC) for
Nottinghamshire, Derbyshire, Lincolnshire (NDL). Implement Sci 2012, 7:40.
44. Bartlett RH: Translating innovation: Beethoven, Gross, Krummel, and
Georgeson. J Pediatr Surg 2011, 46:18–21.
45. Bergman D, Beck A: Moving from research to large-scale change in child
health care. Acad Pediatr 2011, 11:360–368.
46. Rangachari P: Knowledge sharing networks related to hospital quality
measurement and reporting. Health Care Manage Rev 2008, 33:253–263.
47. Burt RS: Structural holes and good ideas. Am J Sociol 2004, 110:349–399.
48. Obstfeld D: Social networks, the tertius iungens orientation, and
involvement in innovation. Adm Sci Q 2005, 50:100–130.
49. Battilana J, Casciaro T: Change agents, networks, and institutions: a
contingency theory of organizational change. Acad Manag J 2012,
55:381–398.
50. Haines V, Godley J, Hawe P: Understanding interdisciplinary collaborations
as social networks. Am J Community Psychol 2011, 47:1–11.
51. Tetroe JM, Graham ID, Foy R, Robinson N, Eccles MP, Wensing M, Durieux P,
Légaré F, Nielson CP, Adily A: Health research funding agencies’ support
and promotion of knowledge translation: an international study. Milbank
Quarterly 2008, 86:125–155.
52. Wasserman S, Faust K: Social network analysis: Methods and applications.
Cambridge university press; 1994.
Long et al. BMC Health Services Research 2013, 13:338 Page 11 of 11
http://www.biomedcentral.com/1472-6963/13/33853. Westfall JM, Mold J, Fagnan L: Practice-based research - “blue highways”
on the NIH roadmap. JAMA 2007, 297:403–406.
54. Long JC, Cunningham FC, Braithwaite J: Network structure and the role of
key players in a translational cancer research network: a study protocol.
BMJ Open 2012, 2. doi:10.1136/bmjopen-2012-001434.
55. Friedkin NE: The development of structure in random networks: an analysis
of the effects of increasing network density on five measures of structure.
Social Networks 1981, 3:41–52.
56. Dauphinée D, Martin JB: Breaking down the walls: thoughts on the
scholarship of integration. Acad Med 2000, 75:881–886.
57. Brass DJ: Being in the right place: a structural analysis of individual
influence in an organization. Adm Sci Q 1984, 29:518–539.
58. Borgatti SP, Everett MG, Freeman LC: UCInet for Windows: software for social
network analysis. 6th edition. Harvard: Analytic Technologies; 2002.
59. Stokols D, Misra S, Moser RP, Hall KL, Taylor BK: The ecology of team
science: understanding contextual influences on transdisciplinary
collaboration. Am J Prev Med 2008, 35:S96–S115.
60. Goodwin N, Perri G, Peck P, Freeman T, Posaner R: Managing across diverse
networks: lessons from other sectors. Report to the national coordinating
centre for the NHS service delivery and organisation R&D programme. London:
London School of Hygiene and Tropical Medicine; 2004.
doi:10.1186/1472-6963-13-338
Cite this article as: Long et al.: Who are the key players in a new
translational research network? BMC Health Services Research 2013 13:338.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
